Kidney Stone Treatment
For acute kidney stones, start with intramuscular diclofenac 75 mg for pain control, then determine treatment based on stone size and location: stones <10 mm can be managed conservatively with medical expulsive therapy using tamsulosin, while larger stones require surgical intervention with ureteroscopy (URS) as first-line for most ureteral stones and percutaneous nephrolithotomy (PCNL) for renal stones >20 mm. 1, 2, 3
Acute Pain Management
- Administer intramuscular diclofenac 75 mg immediately for acute renal colic, which should provide pain relief within 30 minutes 3
- NSAIDs are superior to opioids because they directly decrease ureteral smooth muscle tone and spasm, have fewer side effects, and carry no dependence risk 3
- Reserve opioids (morphine with cyclizine) only when NSAIDs are contraindicated due to cardiovascular disease, gastrointestinal comorbidities, renal insufficiency, heart failure, or peptic ulcer risk 3
- Patients must receive medical assessment within 30 minutes to exclude life-threatening conditions like ruptured aortic aneurysm (especially >60 years) or ectopic pregnancy 3
Emergency Indications Requiring Immediate Hospital Admission
- Shock or fever (suggests infected obstructed kidney—a urologic emergency) 3
- Failure to respond to analgesia within one hour 3
- Abrupt recurrence of severe pain after initial relief 3
- Sepsis and/or anuria require urgent decompression via percutaneous nephrostomy or ureteral stenting 2
Conservative Management vs. Surgical Intervention
When to Observe (Conservative Management)
- Stones ≤10 mm with controlled symptoms can be observed with periodic evaluation for 4-6 weeks maximum 1, 4
- Patients must have well-controlled pain, no clinical evidence of sepsis, and adequate renal functional reserve 1
- Prescribe tamsulosin (alpha-blocker) as medical expulsive therapy, particularly for stones >5 mm in the distal ureter 4, 3
- Instruct patients to drink fluids targeting >2.5 L urine output daily and strain urine to catch stones for analysis 3, 5
- Follow-up imaging within 7 days to monitor stone position and assess for hydronephrosis 1, 3
When to Intervene Surgically
For stones >10 mm, surgical treatment is required in most cases 1, 4
Surgical Treatment Algorithm by Stone Location and Size
Distal Ureteral Stones
- URS is first-line treatment for stones >10 mm 1
- For stones <10 mm, both URS and extracorporeal shock wave lithotripsy (ESWL) are acceptable, though URS yields significantly higher stone-free rates with a single procedure 1
- URS has higher complication rates (3-6% ureteral injury, 1-2% stricture) compared to ESWL but better efficacy 1
Proximal Ureteral Stones
- URS is recommended as first-line treatment regardless of stone size 1
- ESWL is an equivalent option for stones <10 mm 1
Renal Stones (Pelvis, Upper/Middle Calyx)
- For stones <20 mm: flexible URS (fURS) or ESWL are first-line treatments 1
- For stones >20 mm: PCNL is the standard first-line treatment 1, 2
- For stones 10-20 mm, PCNL is an additional option 1
Lower Pole Renal Stones
Asymptomatic Renal Stones
- Active surveillance is acceptable for asymptomatic, non-obstructing stones up to 15 mm 1
- Surgical treatment is indicated for stone growth, associated infection, or specific vocational reasons 1
Technical Considerations for Surgical Procedures
ESWL Best Practices
- Routine prestenting before ESWL does not improve stone-free rates but may reduce steinstrasse 1
- Decrease shockwave frequency from 120 to 60-90/min to improve stone-free rates and reduce tissue damage 1
- Use stepwise energy ramping to minimize renal injury 1
- ESWL is contraindicated in pregnancy, bleeding disorders, uncontrolled UTI, severe obesity, arterial aneurysm near stone, or anatomic obstruction distal to stone 1
- Prescribe alpha-blockers after ESWL to facilitate passage of stone fragments 1
URS Best Practices
- Complete stone removal is the goal; use Ho:YAG laser as gold standard for lithotripsy 1
- Routine prestenting is not required but may improve outcomes for renal stones 1
- Routine post-URS stenting is unnecessary after uncomplicated procedures and may increase morbidity 1
- Stenting is advised with trauma, residual fragments, bleeding, perforation, UTI, or pregnancy 1
- Prescribe alpha-blockers if stent is placed to reduce discomfort; consider antimuscarinics 1
- fURS is recommended when antithrombotic therapy cannot be stopped 1
PCNL Considerations
- PCNL is classified as high bleeding risk procedure 1
- Patients on antithrombotic therapy should be referred to internist before PCNL 1
Stone Type-Specific Medical Management
Uric Acid Stones
- First-line: potassium citrate to alkalinize urine to pH 6.0 (oral chemolysis) 2, 4
- This can dissolve existing stones and prevent new formation 2
Cystine Stones
Struvite Stones
Calcium Stones (Prevention of Recurrence)
- Thiazide diuretics for hypercalciuria 4, 6
- Potassium citrate for hypocitraturia 4, 6
- Maintain dietary calcium at 1000-1200 mg/day (not supplements) 4, 5
- Limit sodium to 2-3 g/day 5
- Limit animal protein to 0.8-1.0 g/kg/day 5
Post-Treatment Follow-Up
- Obtain 24-hour urine collection within 6 months of treatment to assess metabolic risk factors 4
- Repeat annually or more frequently depending on stone activity 4
- Confirm stone clearance with imaging 2
- Obtain stone analysis at least once to guide metabolic evaluation 4, 3
Critical Pitfalls to Avoid
- Never use opioids as first-line for acute pain—NSAIDs are superior and avoid dependence 3
- Never delay admission for fever with obstruction—this is a urologic emergency requiring immediate drainage 3
- Never routinely stent before ESWL—it doesn't improve outcomes 1
- Never routinely stent after uncomplicated URS—it increases morbidity without benefit 1
- Never prescribe allopurinol as first-line for uric acid stones—potassium citrate for alkalinization is correct 4
- Never use calcium supplements for stone prevention—dietary calcium is preferred 4